Trial Profile
A 4-Year Observational Cohort Study to Evaluate the Efficacy of Ipilimumab in Patients With Treatment-Naive Advanced Melanoma with and without Brain Metastases
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2016
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 22 Jan 2016 New trial record